title: In vivo enhancement in bioavailability of atazanavir in the presence of proton-pump inhibitors using mesoporous materials.
authors.affiliation: Nanologica AB, Drottning Kristinas väg 45, 11428 Stockholm, Sweden.
authors.forename: Xin
authors.initials: X
authors.lastname: Xia
authors.forename: Chunfang
authors.initials: C
authors.lastname: Zhou
authors.forename: Lluís
authors.initials: L
authors.lastname: Ballell
authors.forename: Alfonso E
authors.initials: AE
authors.lastname: Garcia-Bennett
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000097:blood*; D000069446:Atazanavir Sulfate; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage* / Q000097:blood*; D016062:Porosity; D054328:Proton Pump Inhibitors / Q000494:pharmacology*; D011725:Pyridines / Q000008:administration & dosage* / Q000097:blood*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012822:Silicon Dioxide / Q000737:chemistry*; D012995:Solubility
chemical_list: D019380:Anti-HIV Agents; D004337:Drug Carriers; D009842:Oligopeptides; D054328:Proton Pump Inhibitors; D011725:Pyridines; D000069446:Atazanavir Sulfate; D012822:Silicon Dioxide